| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Selection, Genetic | 25 | 2019 | 502 | 4.600 |
Why?
|
| Genetic Variation | 36 | 2018 | 1351 | 3.600 |
Why?
|
| Genetics, Population | 20 | 2018 | 394 | 3.130 |
Why?
|
| Glucuronosyltransferase | 12 | 2014 | 184 | 3.080 |
Why?
|
| Polymorphism, Single Nucleotide | 38 | 2018 | 2357 | 2.790 |
Why?
|
| Gene Frequency | 34 | 2019 | 677 | 2.690 |
Why?
|
| Haplotypes | 20 | 2019 | 642 | 2.540 |
Why?
|
| Adaptation, Physiological | 9 | 2022 | 306 | 2.440 |
Why?
|
| Glucocorticoids | 7 | 2014 | 352 | 2.040 |
Why?
|
| Linkage Disequilibrium | 18 | 2013 | 473 | 1.850 |
Why?
|
| Genome, Human | 12 | 2018 | 756 | 1.670 |
Why?
|
| Gene Expression Regulation | 11 | 2017 | 1920 | 1.610 |
Why?
|
| Transcription, Genetic | 6 | 2017 | 1135 | 1.530 |
Why?
|
| Acclimatization | 5 | 2018 | 76 | 1.530 |
Why?
|
| Models, Genetic | 17 | 2019 | 926 | 1.530 |
Why?
|
| Polymorphism, Genetic | 17 | 2012 | 819 | 1.440 |
Why?
|
| Alleles | 20 | 2018 | 1128 | 1.360 |
Why?
|
| Evolution, Molecular | 10 | 2015 | 813 | 1.260 |
Why?
|
| Allelic Imbalance | 3 | 2013 | 20 | 1.210 |
Why?
|
| Calcitriol | 3 | 2017 | 174 | 1.100 |
Why?
|
| Leukocytes, Mononuclear | 3 | 2016 | 196 | 1.070 |
Why?
|
| Gene Flow | 7 | 2017 | 88 | 1.070 |
Why?
|
| Recombination, Genetic | 6 | 2014 | 439 | 0.990 |
Why?
|
| Altitude | 6 | 2022 | 40 | 0.950 |
Why?
|
| Multigene Family | 7 | 2014 | 202 | 0.940 |
Why?
|
| Phenotype | 12 | 2016 | 2378 | 0.920 |
Why?
|
| Multifactorial Inheritance | 2 | 2018 | 159 | 0.920 |
Why?
|
| Genotype | 21 | 2018 | 1851 | 0.910 |
Why?
|
| Humans | 111 | 2022 | 86645 | 0.910 |
Why?
|
| Transcriptome | 5 | 2016 | 580 | 0.900 |
Why?
|
| Climate | 4 | 2011 | 50 | 0.890 |
Why?
|
| Human Migration | 3 | 2019 | 25 | 0.870 |
Why?
|
| Skin Pigmentation | 3 | 2019 | 40 | 0.870 |
Why?
|
| Sequence Analysis, DNA | 11 | 2018 | 853 | 0.860 |
Why?
|
| Breast | 5 | 2011 | 288 | 0.860 |
Why?
|
| DNA, Ancient | 2 | 2019 | 18 | 0.850 |
Why?
|
| Genetic Predisposition to Disease | 13 | 2017 | 2271 | 0.840 |
Why?
|
| Genome-Wide Association Study | 8 | 2018 | 1621 | 0.820 |
Why?
|
| Adaptation, Biological | 2 | 2014 | 85 | 0.800 |
Why?
|
| Environment | 3 | 2014 | 219 | 0.790 |
Why?
|
| Phylogeny | 11 | 2016 | 1137 | 0.760 |
Why?
|
| Lymphocytes | 2 | 2013 | 464 | 0.760 |
Why?
|
| Breast Neoplasms | 7 | 2014 | 2903 | 0.740 |
Why?
|
| Calpain | 3 | 2005 | 111 | 0.700 |
Why?
|
| Receptors, Glucocorticoid | 4 | 2014 | 120 | 0.650 |
Why?
|
| Biological Evolution | 7 | 2011 | 919 | 0.640 |
Why?
|
| Hemoglobins | 3 | 2018 | 179 | 0.610 |
Why?
|
| Diet | 2 | 2010 | 443 | 0.590 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 2 | 2018 | 165 | 0.580 |
Why?
|
| Tibet | 6 | 2022 | 19 | 0.570 |
Why?
|
| Bayes Theorem | 6 | 2019 | 361 | 0.570 |
Why?
|
| Base Sequence | 16 | 2011 | 2330 | 0.540 |
Why?
|
| Population Density | 4 | 2019 | 60 | 0.530 |
Why?
|
| Hominidae | 4 | 2015 | 96 | 0.530 |
Why?
|
| Lipopolysaccharides | 2 | 2016 | 286 | 0.530 |
Why?
|
| Cytochrome P-450 Enzyme System | 2 | 2006 | 79 | 0.520 |
Why?
|
| Genetic Markers | 6 | 2014 | 476 | 0.510 |
Why?
|
| Monocytes | 1 | 2016 | 214 | 0.510 |
Why?
|
| Mutation | 12 | 2011 | 3968 | 0.500 |
Why?
|
| Vitamin D | 2 | 2017 | 261 | 0.500 |
Why?
|
| Hypoxia | 3 | 2018 | 641 | 0.500 |
Why?
|
| Dexamethasone | 3 | 2014 | 326 | 0.490 |
Why?
|
| Hypoxia-Inducible Factor-Proline Dioxygenases | 1 | 2014 | 3 | 0.490 |
Why?
|
| Cell Proliferation | 3 | 2016 | 1578 | 0.480 |
Why?
|
| Biomarkers, Pharmacological | 1 | 2014 | 22 | 0.480 |
Why?
|
| Cytochrome P-450 CYP3A | 3 | 2008 | 43 | 0.470 |
Why?
|
| DNA | 8 | 2017 | 1294 | 0.460 |
Why?
|
| Hylobates | 1 | 2013 | 4 | 0.450 |
Why?
|
| Molecular Sequence Data | 13 | 2011 | 3030 | 0.430 |
Why?
|
| Primates | 3 | 2005 | 151 | 0.430 |
Why?
|
| Binding Sites | 6 | 2016 | 1098 | 0.430 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2014 | 166 | 0.420 |
Why?
|
| DNA, Complementary | 1 | 2013 | 393 | 0.420 |
Why?
|
| Gene Expression Profiling | 7 | 2017 | 1384 | 0.420 |
Why?
|
| Animals | 28 | 2016 | 26582 | 0.420 |
Why?
|
| Liver | 4 | 2011 | 1230 | 0.410 |
Why?
|
| Enhancer Elements, Genetic | 3 | 2011 | 266 | 0.410 |
Why?
|
| Quantitative Trait Loci | 6 | 2017 | 576 | 0.410 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2010 | 302 | 0.410 |
Why?
|
| Chromosome Mapping | 8 | 2016 | 1074 | 0.400 |
Why?
|
| Duffy Blood-Group System | 2 | 2001 | 7 | 0.400 |
Why?
|
| Interleukin-6 | 2 | 2014 | 256 | 0.390 |
Why?
|
| 3' Untranslated Regions | 1 | 2011 | 92 | 0.390 |
Why?
|
| Regulatory Elements, Transcriptional | 1 | 2011 | 45 | 0.390 |
Why?
|
| Gene-Environment Interaction | 1 | 2012 | 103 | 0.390 |
Why?
|
| Inflammatory Bowel Diseases | 2 | 2015 | 549 | 0.390 |
Why?
|
| Cold Climate | 1 | 2010 | 4 | 0.390 |
Why?
|
| Nutritional Physiological Phenomena | 1 | 2010 | 27 | 0.380 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2011 | 154 | 0.380 |
Why?
|
| Mammography | 1 | 2014 | 463 | 0.380 |
Why?
|
| Body Temperature Regulation | 1 | 2010 | 56 | 0.380 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2013 | 339 | 0.370 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2010 | 12 | 0.370 |
Why?
|
| Italy | 9 | 2011 | 106 | 0.370 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2005 | 1373 | 0.370 |
Why?
|
| Female | 31 | 2018 | 44534 | 0.360 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 3 | 2016 | 148 | 0.360 |
Why?
|
| NF-kappa B | 1 | 2013 | 444 | 0.360 |
Why?
|
| Gene Expression | 4 | 2013 | 1284 | 0.350 |
Why?
|
| Mitochondrial Proteins | 1 | 2010 | 123 | 0.350 |
Why?
|
| Protein Binding | 4 | 2016 | 1456 | 0.350 |
Why?
|
| Africa | 7 | 2011 | 98 | 0.350 |
Why?
|
| Thalassemia | 9 | 1991 | 16 | 0.340 |
Why?
|
| Nepal | 6 | 2022 | 14 | 0.340 |
Why?
|
| Ion Channels | 1 | 2010 | 246 | 0.330 |
Why?
|
| Microsatellite Repeats | 2 | 2000 | 145 | 0.330 |
Why?
|
| Europe | 6 | 2019 | 309 | 0.330 |
Why?
|
| Genome | 3 | 2022 | 372 | 0.330 |
Why?
|
| Alternative Splicing | 1 | 2009 | 201 | 0.310 |
Why?
|
| Metabolic Diseases | 1 | 2008 | 48 | 0.300 |
Why?
|
| Genomics | 5 | 2016 | 720 | 0.300 |
Why?
|
| Computational Biology | 4 | 2016 | 528 | 0.300 |
Why?
|
| alpha 1-Antitrypsin | 1 | 2006 | 16 | 0.300 |
Why?
|
| Pseudogenes | 1 | 2006 | 35 | 0.290 |
Why?
|
| Asthma | 2 | 2014 | 955 | 0.290 |
Why?
|
| Genetic Heterogeneity | 2 | 2015 | 62 | 0.290 |
Why?
|
| Spermatozoa | 1 | 2006 | 62 | 0.290 |
Why?
|
| Polymerase Chain Reaction | 6 | 2005 | 927 | 0.290 |
Why?
|
| B-Lymphocytes | 1 | 2011 | 724 | 0.280 |
Why?
|
| Species Specificity | 5 | 2016 | 678 | 0.270 |
Why?
|
| Genetic Linkage | 4 | 2005 | 623 | 0.260 |
Why?
|
| Receptors, Steroid | 1 | 2005 | 42 | 0.260 |
Why?
|
| Receptors, Calcitriol | 2 | 2016 | 129 | 0.260 |
Why?
|
| DNA Primers | 4 | 2005 | 543 | 0.260 |
Why?
|
| Pan troglodytes | 5 | 2013 | 197 | 0.260 |
Why?
|
| Water-Electrolyte Balance | 1 | 2004 | 66 | 0.250 |
Why?
|
| Prion Diseases | 1 | 2004 | 32 | 0.250 |
Why?
|
| Prions | 1 | 2004 | 54 | 0.240 |
Why?
|
| Beta-Globulins | 1 | 2003 | 4 | 0.240 |
Why?
|
| DNA, Mitochondrial | 5 | 2017 | 183 | 0.240 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2005 | 115 | 0.240 |
Why?
|
| Proteins | 1 | 2009 | 777 | 0.230 |
Why?
|
| Cell Line | 4 | 2013 | 2468 | 0.230 |
Why?
|
| Male | 23 | 2017 | 40967 | 0.230 |
Why?
|
| Promoter Regions, Genetic | 4 | 2002 | 937 | 0.220 |
Why?
|
| Transcription Factors | 4 | 2013 | 1565 | 0.220 |
Why?
|
| Cluster Analysis | 3 | 2016 | 369 | 0.210 |
Why?
|
| Time Factors | 6 | 2019 | 5210 | 0.210 |
Why?
|
| Geography | 4 | 2010 | 223 | 0.210 |
Why?
|
| Gene Conversion | 1 | 2001 | 25 | 0.200 |
Why?
|
| Likelihood Functions | 4 | 2017 | 251 | 0.200 |
Why?
|
| Demography | 2 | 2002 | 177 | 0.190 |
Why?
|
| Dogs | 3 | 2014 | 685 | 0.190 |
Why?
|
| Chromosome Deletion | 5 | 1990 | 229 | 0.190 |
Why?
|
| Regulatory-Associated Protein of mTOR | 2 | 2010 | 11 | 0.180 |
Why?
|
| Genetics, Medical | 1 | 2000 | 52 | 0.180 |
Why?
|
| Globins | 8 | 1990 | 31 | 0.180 |
Why?
|
| Chromatin Immunoprecipitation | 2 | 2010 | 133 | 0.180 |
Why?
|
| Receptors, Cell Surface | 1 | 2001 | 286 | 0.180 |
Why?
|
| Principal Component Analysis | 2 | 2017 | 155 | 0.180 |
Why?
|
| Middle Aged | 9 | 2018 | 25028 | 0.180 |
Why?
|
| Young Adult | 6 | 2015 | 5976 | 0.180 |
Why?
|
| Sequence Deletion | 2 | 2015 | 205 | 0.180 |
Why?
|
| Temperature | 2 | 2011 | 396 | 0.180 |
Why?
|
| Population | 2 | 2015 | 35 | 0.170 |
Why?
|
| Adult | 14 | 2018 | 25648 | 0.170 |
Why?
|
| DNA, Satellite | 2 | 1998 | 18 | 0.170 |
Why?
|
| Indians, South American | 1 | 2018 | 5 | 0.170 |
Why?
|
| Membrane Glycoproteins | 1 | 2001 | 428 | 0.170 |
Why?
|
| Immediate-Early Proteins | 2 | 2011 | 164 | 0.170 |
Why?
|
| Siberia | 2 | 2015 | 12 | 0.170 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2018 | 100 | 0.160 |
Why?
|
| Emigration and Immigration | 3 | 2012 | 48 | 0.160 |
Why?
|
| Sequence Alignment | 2 | 2011 | 351 | 0.160 |
Why?
|
| Genetic Drift | 1 | 2017 | 37 | 0.150 |
Why?
|
| Genetic Diseases, Inborn | 1 | 1998 | 101 | 0.150 |
Why?
|
| Ethiopia | 4 | 2013 | 37 | 0.150 |
Why?
|
| Germ-Line Mutation | 1 | 2000 | 329 | 0.150 |
Why?
|
| Uridine Phosphorylase | 1 | 2017 | 4 | 0.150 |
Why?
|
| Energy Metabolism | 2 | 2010 | 271 | 0.150 |
Why?
|
| Origin of Life | 1 | 2016 | 4 | 0.150 |
Why?
|
| Population Surveillance | 1 | 1998 | 219 | 0.150 |
Why?
|
| Drosophila Proteins | 1 | 2001 | 488 | 0.140 |
Why?
|
| Mutation Rate | 1 | 2016 | 48 | 0.140 |
Why?
|
| Nucleotide Motifs | 1 | 2016 | 47 | 0.140 |
Why?
|
| Chromosomes, Artificial, Yeast | 1 | 1996 | 37 | 0.140 |
Why?
|
| Cell Line, Tumor | 3 | 2013 | 2426 | 0.140 |
Why?
|
| Russia | 1 | 2015 | 25 | 0.140 |
Why?
|
| Adaptive Immunity | 2 | 2014 | 164 | 0.130 |
Why?
|
| Endothelial Cells | 1 | 2018 | 428 | 0.130 |
Why?
|
| Australia | 2 | 2016 | 99 | 0.130 |
Why?
|
| Japan | 1 | 2015 | 307 | 0.130 |
Why?
|
| Genetic Association Studies | 2 | 2014 | 294 | 0.130 |
Why?
|
| Nigeria | 2 | 2013 | 152 | 0.130 |
Why?
|
| Mifepristone | 1 | 2014 | 33 | 0.130 |
Why?
|
| Gene Duplication | 1 | 2015 | 125 | 0.130 |
Why?
|
| Pharmacogenetics | 2 | 2014 | 434 | 0.120 |
Why?
|
| DNA Copy Number Variations | 1 | 2015 | 171 | 0.120 |
Why?
|
| Cameroon | 2 | 2005 | 14 | 0.120 |
Why?
|
| HIV Envelope Protein gp120 | 1 | 1994 | 19 | 0.120 |
Why?
|
| RNA, Messenger | 2 | 2011 | 1981 | 0.120 |
Why?
|
| Albumins | 1 | 2014 | 133 | 0.120 |
Why?
|
| Coronary Artery Disease | 1 | 2018 | 350 | 0.120 |
Why?
|
| Brain Ischemia | 1 | 2018 | 398 | 0.120 |
Why?
|
| Octamer Transcription Factor-1 | 2 | 2010 | 17 | 0.120 |
Why?
|
| Fourier Analysis | 1 | 2014 | 125 | 0.120 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 1994 | 135 | 0.120 |
Why?
|
| Cells, Cultured | 2 | 2016 | 2818 | 0.120 |
Why?
|
| Antimicrobial Cationic Peptides | 1 | 2013 | 13 | 0.120 |
Why?
|
| Electron Transport | 1 | 2013 | 71 | 0.120 |
Why?
|
| Aged, 80 and over | 2 | 2018 | 6509 | 0.120 |
Why?
|
| Models, Biological | 2 | 2011 | 1749 | 0.120 |
Why?
|
| Colon | 1 | 2017 | 496 | 0.120 |
Why?
|
| History, Ancient | 3 | 2022 | 74 | 0.120 |
Why?
|
| Immunity, Innate | 2 | 2014 | 409 | 0.120 |
Why?
|
| Colonic Neoplasms | 1 | 1998 | 556 | 0.120 |
Why?
|
| China | 2 | 2005 | 228 | 0.110 |
Why?
|
| Genetic Loci | 2 | 2015 | 250 | 0.110 |
Why?
|
| Chromosomes, Fungal | 1 | 1993 | 15 | 0.110 |
Why?
|
| Vitamins | 1 | 2013 | 81 | 0.110 |
Why?
|
| Altitude Sickness | 1 | 2012 | 10 | 0.110 |
Why?
|
| Neovascularization, Physiologic | 1 | 2013 | 133 | 0.110 |
Why?
|
| Drug Synergism | 1 | 2013 | 303 | 0.110 |
Why?
|
| Algorithms | 2 | 2014 | 1830 | 0.110 |
Why?
|
| Pongo pygmaeus | 3 | 2001 | 10 | 0.110 |
Why?
|
| Hemoglobin H | 3 | 1987 | 3 | 0.110 |
Why?
|
| HIV-1 | 1 | 1994 | 163 | 0.110 |
Why?
|
| Gene Library | 1 | 1993 | 130 | 0.110 |
Why?
|
| Paclitaxel | 1 | 2014 | 460 | 0.110 |
Why?
|
| Indians, North American | 1 | 2012 | 48 | 0.110 |
Why?
|
| Computer Simulation | 2 | 2015 | 1078 | 0.110 |
Why?
|
| CpG Islands | 1 | 2012 | 151 | 0.110 |
Why?
|
| Coyotes | 1 | 2011 | 5 | 0.100 |
Why?
|
| Extinction, Biological | 1 | 2013 | 85 | 0.100 |
Why?
|
| Wolves | 1 | 2011 | 10 | 0.100 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 2011 | 173 | 0.100 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2013 | 407 | 0.100 |
Why?
|
| NAD(P)H Dehydrogenase (Quinone) | 1 | 2011 | 8 | 0.100 |
Why?
|
| Homozygote | 3 | 2010 | 200 | 0.100 |
Why?
|
| NF-kappa B p50 Subunit | 1 | 2011 | 41 | 0.100 |
Why?
|
| HapMap Project | 1 | 2011 | 47 | 0.100 |
Why?
|
| Neovascularization, Pathologic | 1 | 2013 | 353 | 0.100 |
Why?
|
| RNA-Binding Proteins | 1 | 2013 | 246 | 0.100 |
Why?
|
| Cell Line, Transformed | 1 | 2011 | 154 | 0.100 |
Why?
|
| Crohn Disease | 2 | 2015 | 730 | 0.100 |
Why?
|
| Pilot Projects | 1 | 2014 | 839 | 0.100 |
Why?
|
| Meiosis | 1 | 2011 | 80 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2011 | 30 | 0.100 |
Why?
|
| T-Lymphocytes | 2 | 2014 | 1195 | 0.100 |
Why?
|
| Retinoids | 1 | 2010 | 17 | 0.100 |
Why?
|
| Gene Regulatory Networks | 1 | 2013 | 296 | 0.100 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2011 | 416 | 0.100 |
Why?
|
| Tetrahydronaphthalenes | 1 | 2010 | 15 | 0.100 |
Why?
|
| Colitis, Ulcerative | 2 | 2015 | 711 | 0.100 |
Why?
|
| Retinoid X Receptors | 1 | 2010 | 39 | 0.100 |
Why?
|
| Uncoupling Protein 3 | 1 | 2010 | 9 | 0.100 |
Why?
|
| Uncoupling Protein 2 | 1 | 2010 | 11 | 0.100 |
Why?
|
| Lymphocyte Activation | 1 | 1994 | 728 | 0.100 |
Why?
|
| Transcription Initiation Site | 1 | 2010 | 45 | 0.100 |
Why?
|
| Hep G2 Cells | 1 | 2010 | 48 | 0.100 |
Why?
|
| Benzoates | 1 | 2010 | 44 | 0.100 |
Why?
|
| Trans-Activators | 1 | 2013 | 429 | 0.100 |
Why?
|
| Uncoupling Protein 1 | 1 | 2010 | 35 | 0.100 |
Why?
|
| Transcriptional Activation | 1 | 2011 | 280 | 0.090 |
Why?
|
| Adenocarcinoma | 1 | 1998 | 1169 | 0.090 |
Why?
|
| Culture | 1 | 2010 | 53 | 0.090 |
Why?
|
| Databases, Factual | 1 | 2014 | 814 | 0.090 |
Why?
|
| Camptothecin | 2 | 2002 | 189 | 0.090 |
Why?
|
| Hemoglobins, Abnormal | 2 | 1986 | 5 | 0.090 |
Why?
|
| Ultraviolet Rays | 1 | 2011 | 193 | 0.090 |
Why?
|
| Pigmentation | 1 | 2010 | 69 | 0.090 |
Why?
|
| Aged | 4 | 2018 | 18415 | 0.090 |
Why?
|
| Databases, Genetic | 1 | 2011 | 260 | 0.090 |
Why?
|
| Ecology | 1 | 2010 | 74 | 0.090 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2010 | 41 | 0.090 |
Why?
|
| Software | 1 | 2014 | 654 | 0.090 |
Why?
|
| Precision Medicine | 1 | 2014 | 395 | 0.090 |
Why?
|
| Stroke | 1 | 2018 | 965 | 0.090 |
Why?
|
| Base Pairing | 2 | 2006 | 55 | 0.090 |
Why?
|
| Odds Ratio | 1 | 2011 | 678 | 0.090 |
Why?
|
| Founder Effect | 2 | 2000 | 104 | 0.090 |
Why?
|
| Organ Specificity | 1 | 2010 | 258 | 0.090 |
Why?
|
| Down-Regulation | 1 | 2010 | 504 | 0.080 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2009 | 268 | 0.080 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2014 | 1197 | 0.080 |
Why?
|
| Midazolam | 1 | 2008 | 48 | 0.080 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2011 | 381 | 0.080 |
Why?
|
| Homeostasis | 1 | 2010 | 409 | 0.080 |
Why?
|
| Antiporters | 1 | 2008 | 18 | 0.080 |
Why?
|
| DNA Methylation | 1 | 2012 | 628 | 0.080 |
Why?
|
| Amino Acid Sequence | 1 | 2011 | 2062 | 0.080 |
Why?
|
| Signal Transduction | 3 | 2013 | 3241 | 0.080 |
Why?
|
| Asia | 3 | 2012 | 95 | 0.080 |
Why?
|
| Ecosystem | 1 | 2010 | 316 | 0.070 |
Why?
|
| Phylogeography | 2 | 2017 | 41 | 0.070 |
Why?
|
| Serpins | 1 | 2006 | 29 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 16 | 1 | 1986 | 79 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 14 | 1 | 2006 | 49 | 0.070 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2008 | 879 | 0.070 |
Why?
|
| Transfection | 1 | 2008 | 896 | 0.070 |
Why?
|
| Case-Control Studies | 1 | 2011 | 1805 | 0.070 |
Why?
|
| Glucokinase | 1 | 2006 | 61 | 0.070 |
Why?
|
| Monte Carlo Method | 2 | 2010 | 185 | 0.070 |
Why?
|
| Metabolic Syndrome | 1 | 2008 | 141 | 0.070 |
Why?
|
| Birth Weight | 1 | 2006 | 145 | 0.070 |
Why?
|
| Papio | 1 | 2006 | 82 | 0.070 |
Why?
|
| Risk Factors | 3 | 2015 | 5417 | 0.070 |
Why?
|
| Mice | 2 | 2011 | 11352 | 0.060 |
Why?
|
| Los Angeles | 1 | 2004 | 28 | 0.060 |
Why?
|
| Mexican Americans | 1 | 2005 | 63 | 0.060 |
Why?
|
| Sodium Chloride | 1 | 2004 | 88 | 0.060 |
Why?
|
| Mutagenesis | 2 | 2001 | 199 | 0.060 |
Why?
|
| Conserved Sequence | 1 | 2004 | 210 | 0.060 |
Why?
|
| Protein Conformation | 1 | 2006 | 881 | 0.060 |
Why?
|
| Predictive Value of Tests | 1 | 2008 | 1673 | 0.060 |
Why?
|
| India | 2 | 2017 | 120 | 0.060 |
Why?
|
| Bilirubin | 2 | 2002 | 125 | 0.060 |
Why?
|
| Microsomes, Liver | 1 | 2002 | 49 | 0.060 |
Why?
|
| Blood Glucose | 1 | 2006 | 873 | 0.050 |
Why?
|
| Pakistan | 1 | 2001 | 15 | 0.050 |
Why?
|
| Haplorhini | 1 | 2002 | 81 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 2 | 1 | 2002 | 85 | 0.050 |
Why?
|
| Base Composition | 1 | 2001 | 35 | 0.050 |
Why?
|
| Pan paniscus | 1 | 2001 | 10 | 0.050 |
Why?
|
| Crossing Over, Genetic | 1 | 2001 | 33 | 0.050 |
Why?
|
| Receptors, Interleukin-4 | 1 | 2001 | 9 | 0.050 |
Why?
|
| DNA Restriction Enzymes | 5 | 1989 | 98 | 0.050 |
Why?
|
| Gorilla gorilla | 1 | 2001 | 41 | 0.050 |
Why?
|
| Sample Size | 1 | 2001 | 130 | 0.050 |
Why?
|
| Gene Pool | 1 | 2000 | 6 | 0.050 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2002 | 203 | 0.050 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2001 | 88 | 0.050 |
Why?
|
| Toll-Like Receptors | 1 | 2001 | 92 | 0.050 |
Why?
|
| HLA Antigens | 1 | 2002 | 232 | 0.050 |
Why?
|
| Biomarkers, Tumor | 1 | 2008 | 1464 | 0.050 |
Why?
|
| Plasmodium vivax | 1 | 2000 | 1 | 0.050 |
Why?
|
| Retrospective Studies | 2 | 2014 | 8491 | 0.050 |
Why?
|
| Amino Acids | 1 | 2001 | 252 | 0.050 |
Why?
|
| Africa South of the Sahara | 1 | 2000 | 21 | 0.050 |
Why?
|
| Dinucleotide Repeats | 1 | 1999 | 13 | 0.050 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2014 | 689 | 0.040 |
Why?
|
| Nucleic Acid Hybridization | 4 | 1993 | 245 | 0.040 |
Why?
|
| Rats | 1 | 2006 | 3990 | 0.040 |
Why?
|
| Human Genome Project | 1 | 1998 | 19 | 0.040 |
Why?
|
| Hemoglobinopathies | 2 | 1989 | 10 | 0.040 |
Why?
|
| Fetal Hemoglobin | 2 | 1989 | 14 | 0.040 |
Why?
|
| Whole Genome Sequencing | 1 | 2018 | 76 | 0.040 |
Why?
|
| Hepatitis B | 2 | 1989 | 74 | 0.040 |
Why?
|
| Blotting, Southern | 2 | 1996 | 129 | 0.040 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2018 | 93 | 0.040 |
Why?
|
| Discriminant Analysis | 1 | 1998 | 66 | 0.040 |
Why?
|
| Blood Flow Velocity | 1 | 2018 | 197 | 0.040 |
Why?
|
| Myanmar | 1 | 2017 | 3 | 0.040 |
Why?
|
| Population Dynamics | 1 | 2018 | 130 | 0.040 |
Why?
|
| Mechanotransduction, Cellular | 1 | 2018 | 77 | 0.040 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 1999 | 276 | 0.040 |
Why?
|
| United States | 3 | 2017 | 6674 | 0.040 |
Why?
|
| Genetic Testing | 2 | 1998 | 535 | 0.040 |
Why?
|
| Middle East | 2 | 2000 | 17 | 0.040 |
Why?
|
| Chromosomes, Human, Y | 1 | 2017 | 22 | 0.040 |
Why?
|
| New Guinea | 1 | 2016 | 1 | 0.040 |
Why?
|
| Organ Culture Techniques | 1 | 2017 | 135 | 0.040 |
Why?
|
| Neanderthals | 1 | 2016 | 15 | 0.040 |
Why?
|
| Paleodontology | 1 | 2016 | 11 | 0.040 |
Why?
|
| Datasets as Topic | 1 | 2016 | 71 | 0.040 |
Why?
|
| DNA, Recombinant | 1 | 1996 | 67 | 0.030 |
Why?
|
| Chromatin | 1 | 2018 | 380 | 0.030 |
Why?
|
| Leukocytes | 1 | 2017 | 202 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 4 | 1 | 1995 | 48 | 0.030 |
Why?
|
| Hemodynamics | 1 | 2018 | 711 | 0.030 |
Why?
|
| Goats | 1 | 2014 | 18 | 0.030 |
Why?
|
| Canidae | 1 | 2014 | 5 | 0.030 |
Why?
|
| Spermatocytes | 1 | 2014 | 8 | 0.030 |
Why?
|
| Phytohemagglutinins | 1 | 2014 | 22 | 0.030 |
Why?
|
| Sheep | 1 | 2014 | 239 | 0.030 |
Why?
|
| Interleukin-1beta | 1 | 2014 | 78 | 0.030 |
Why?
|
| CD3 Complex | 1 | 2014 | 135 | 0.030 |
Why?
|
| HIV Envelope Protein gp160 | 1 | 1994 | 2 | 0.030 |
Why?
|
| Gene Products, env | 1 | 1994 | 5 | 0.030 |
Why?
|
| CD28 Antigens | 1 | 2014 | 88 | 0.030 |
Why?
|
| Hepcidins | 1 | 2013 | 4 | 0.030 |
Why?
|
| Oxyhemoglobins | 1 | 2013 | 31 | 0.030 |
Why?
|
| Polymorphism, Restriction Fragment Length | 3 | 1990 | 147 | 0.030 |
Why?
|
| Ferritins | 1 | 2013 | 29 | 0.030 |
Why?
|
| Drug Resistance | 1 | 2014 | 256 | 0.030 |
Why?
|
| Protein Precursors | 1 | 1994 | 143 | 0.030 |
Why?
|
| Erythropoietin | 1 | 2013 | 91 | 0.030 |
Why?
|
| Biopsy | 1 | 2017 | 1163 | 0.030 |
Why?
|
| DNA Probes | 1 | 1993 | 77 | 0.030 |
Why?
|
| Hepatitis B Antibodies | 2 | 1989 | 15 | 0.030 |
Why?
|
| Americas | 1 | 2012 | 19 | 0.030 |
Why?
|
| Evaluation Studies as Topic | 1 | 1993 | 274 | 0.030 |
Why?
|
| Mammals | 1 | 2014 | 227 | 0.030 |
Why?
|
| Gene Amplification | 1 | 1993 | 131 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2013 | 376 | 0.030 |
Why?
|
| X Chromosome | 1 | 1993 | 152 | 0.030 |
Why?
|
| Colorectal Neoplasms | 1 | 2000 | 938 | 0.030 |
Why?
|
| Cell Cycle | 1 | 1994 | 502 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 1994 | 1014 | 0.030 |
Why?
|
| Genetic Vectors | 1 | 1993 | 439 | 0.020 |
Why?
|
| Immune Tolerance | 1 | 1994 | 337 | 0.020 |
Why?
|
| Introns | 2 | 2007 | 289 | 0.020 |
Why?
|
| Malaria | 1 | 1991 | 23 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2013 | 999 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2017 | 1208 | 0.020 |
Why?
|
| Space-Time Clustering | 2 | 1988 | 3 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2011 | 307 | 0.020 |
Why?
|
| Biomarkers | 2 | 2014 | 1718 | 0.020 |
Why?
|
| Hepatitis B e Antigens | 1 | 1989 | 8 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2017 | 2767 | 0.020 |
Why?
|
| Markov Chains | 1 | 2010 | 125 | 0.020 |
Why?
|
| Hepatitis B virus | 1 | 1989 | 43 | 0.020 |
Why?
|
| Carrier State | 1 | 1989 | 39 | 0.020 |
Why?
|
| Egypt | 3 | 1999 | 13 | 0.020 |
Why?
|
| Placenta | 1 | 1991 | 175 | 0.020 |
Why?
|
| Neurosecretory Systems | 1 | 2009 | 35 | 0.020 |
Why?
|
| DNA, Viral | 1 | 1989 | 265 | 0.020 |
Why?
|
| Anemia, Sickle Cell | 2 | 1990 | 131 | 0.020 |
Why?
|
| Taste | 1 | 2008 | 28 | 0.020 |
Why?
|
| Internet | 1 | 2010 | 312 | 0.020 |
Why?
|
| Stress, Physiological | 1 | 2009 | 227 | 0.020 |
Why?
|
| Prevalence | 2 | 2008 | 1239 | 0.020 |
Why?
|
| Africa, Northern | 1 | 1986 | 5 | 0.020 |
Why?
|
| Macular Degeneration | 1 | 2008 | 59 | 0.020 |
Why?
|
| Greece | 1 | 1986 | 19 | 0.020 |
Why?
|
| Epidemiologic Research Design | 1 | 2006 | 22 | 0.020 |
Why?
|
| Fasting | 1 | 2006 | 161 | 0.020 |
Why?
|
| Risk | 1 | 2007 | 674 | 0.020 |
Why?
|
| Sickle Cell Trait | 1 | 1986 | 21 | 0.020 |
Why?
|
| Exons | 1 | 2007 | 450 | 0.020 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 1985 | 49 | 0.020 |
Why?
|
| Atherosclerosis | 1 | 2008 | 244 | 0.020 |
Why?
|
| Infant, Newborn | 2 | 2006 | 2379 | 0.020 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2014 | 2438 | 0.020 |
Why?
|
| Pregnancy | 1 | 1991 | 2894 | 0.010 |
Why?
|
| Glucuronides | 1 | 2002 | 34 | 0.010 |
Why?
|
| Topoisomerase I Inhibitors | 1 | 2002 | 33 | 0.010 |
Why?
|
| Phenobarbital | 1 | 2002 | 33 | 0.010 |
Why?
|
| Africa, Western | 1 | 2002 | 10 | 0.010 |
Why?
|
| HLA-G Antigens | 1 | 2002 | 52 | 0.010 |
Why?
|
| Extrachromosomal Inheritance | 1 | 2000 | 5 | 0.010 |
Why?
|
| Adolescent | 5 | 1998 | 8982 | 0.010 |
Why?
|
| Protein Subunits | 1 | 2001 | 122 | 0.010 |
Why?
|
| Databases as Topic | 1 | 2000 | 92 | 0.010 |
Why?
|
| Sudan | 1 | 1999 | 13 | 0.010 |
Why?
|
| Hypertension | 1 | 2008 | 1141 | 0.010 |
Why?
|
| Cuba | 2 | 1990 | 5 | 0.010 |
Why?
|
| Consanguinity | 1 | 1998 | 73 | 0.010 |
Why?
|
| Child | 2 | 2006 | 6928 | 0.010 |
Why?
|
| Bronchial Hyperreactivity | 1 | 1998 | 77 | 0.010 |
Why?
|
| DNA Mutational Analysis | 1 | 1999 | 526 | 0.010 |
Why?
|
| Prostatic Neoplasms | 1 | 2008 | 1721 | 0.010 |
Why?
|
| Finland | 1 | 1995 | 29 | 0.010 |
Why?
|
| Codon | 1 | 1993 | 124 | 0.010 |
Why?
|
| Child, Preschool | 1 | 1998 | 3613 | 0.010 |
Why?
|
| Electrophoresis, Cellulose Acetate | 1 | 1991 | 3 | 0.010 |
Why?
|
| Plasmodium falciparum | 1 | 1991 | 47 | 0.010 |
Why?
|
| Radioimmunoassay | 1 | 1989 | 155 | 0.010 |
Why?
|
| Erythrocytes | 1 | 1991 | 255 | 0.010 |
Why?
|
| Heterozygote | 1 | 1991 | 365 | 0.010 |
Why?
|
| Prenatal Diagnosis | 1 | 1990 | 104 | 0.010 |
Why?
|
| Hepatitis B Antigens | 1 | 1988 | 2 | 0.010 |
Why?
|
| Pedigree | 1 | 1989 | 966 | 0.000 |
Why?
|
| Military Personnel | 1 | 1988 | 85 | 0.000 |
Why?
|
| Hemoglobin, Sickle | 1 | 1986 | 19 | 0.000 |
Why?
|